En poursuivant votre navigation sur ce site, vous acceptez l'utilisation d'un simple cookie d'identification. Aucune autre exploitation n'est faite de ce cookie. OK
0

The immune paradox of sarcoidosis and regulatory T cells.

Favoris Signaler une erreur
Article
H

Miyara, M. ; Amoura, Z. ; Parizot, C. ; Badoual, C. ; Dorgham, K. ; Trad, S. ; Kambouchner, M. ; Valeyre, D. ; Chapelon-Abric, C. ; Debret, P. ; Piette, J.C. ; Gorochov, G. ; Brasnu, D. ; Tartour, Eric

JOURNAL OF EXPERIMENTAL MEDICINE

Institut National de la Santé et de la Recherche Médicale (INSERM) U543, Immunologie A, 75013 Paris, France.

2006

Article

Url / Doi : http://www.jem.org/cgi/reprint/203/2/359

Volume : 203: 359-370.

Sarcoidosis is characterized by extensive local inflammation (granuloma, cytokine secretion) associated with anergy (poor response to antigens in vitro and in vivo). We postulated that this paradoxical situation would correspond to a disequilibrium between effector and regulatory T lymphocytes (T reg cells). We show that CD4+CD25(bright)FoxP3+ cells accumulate at the periphery of sarcoid granulomas, in bronchoalveolar lavage fluid, and in peripheral blood of patients with active disease. These cells exhibited powerful antiproliferative activity, yet did not completely inhibit TNF-alpha production. Sarcoidosis is therefore associated with a global T reg cell subset amplification whose activity would be insufficient to control local inflammation. At the same time, peripheral T reg cells exert powerful antiproliferative activity that may account for the state of anergy. Altogether, these findings advance our conceptual understanding of immune regulation in a way that resolves the immune paradox of sarcoidosis and permit us to envisage a profound clinical impact of T reg cell manipulation on immunity.
Favoris Signaler une erreur